Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

15 juin 2022 08h18 HE | Source: Research and Markets

Global mTOR (Mammalian Target of Rapamycin) Inhibitors Markets, 2022-2030 with 2021 as the Base Year - Increasing Product Approvals from Regulatory Bodies is Expected to Drive Growth

Dublin, June 15, 2022 (GLOBE NEWSWIRE) -- The "mTOR Inhibitors Market, by Drug Type, By Indication, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and...
14 oct. 2021 07h13 HE | Source: Research and Markets

Global Neuroendocrine Tumors Market & Drug Forecast 2021-2030 | Most Important Unmet Needs and the Projected Impact of 5 Late-Stage Pipeline Agents Entering the Market

Dublin, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The "Neuroendocrine Tumors - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. The market of...
04 mars 2021 06h48 HE | Source: Research and Markets

Global Neuroendocrine Tumors (NET) Market Spotlight 2020-2028

Dublin, March 04, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Neuroendocrine tumors (NET)" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the...
27 oct. 2017 05h01 HE | Source: Future Market Insights Global and Consulting Pvt. Ltd.

Global Neuroendocrine Carcinoma Market to Generate US$ 2.5 Bn by 2027 End – Future Market Insights

Valley Cottage, New York, Oct. 27, 2017 (GLOBE NEWSWIRE) -- Recently, FMI has presented value analysis and insights on the various disease types, treatment types and end users associated with the...

Page précédente